Evidence map›Paper›PMID 42654742›Full record

ArticlePathogens (Basel, Switzerland)2026

Severe HBV-Associated Hepatitis in Infants from the Same Family: Two Clinical Cases with Different Outcomes.

Petar Vasilev, Zhelyazko Badarov, Angel Todev, Petya Argirova, Velina Stoeva, Boriana Chopova, Maria Atanasova, Ivan Baltadzhiev, Mariyana Stoycheva-Vartigova

Abstract readCase Reports
In one paragraph

Article in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Petar VasilevDepartment of Infectious Diseases, Parasitology and Tropical Medicine, Faculty of Medicine, Medical University, 4002 Plovdiv, Bulgaria.ORCID 0000-0002-0573-9889
Zhelyazko BadarovDepartment of Infectious Diseases, Parasitology and Tropical Medicine, Faculty of Medicine, Medical University, 4002 Plovdiv, Bulgaria.
Angel TodevDepartment of Infectious Diseases, Parasitology and Tropical Medicine, Faculty of Medicine, Medical University, 4002 Plovdiv, Bulgaria.
Petya ArgirovaDepartment of Infectious Diseases, Parasitology and Tropical Medicine, Faculty of Medicine, Medical University, 4002 Plovdiv, Bulgaria.ORCID 0000-0003-2223-9058
Velina StoevaSection of Epidemiology, Department of Epidemiology and Disaster Medicine, Faculty of Public Health, Medical University, 4002 Plovdiv, Bulgaria.ORCID 0000-0002-6239-4418
Boriana ChopovaFaculty of Medicine, Medical University, 4002 Plovdiv, Bulgaria.
Maria AtanasovaLaboratory of Virology, University Multipurpose Hospital for Active Treatment "Sveti Georgi", 4002 Plovdiv, Bulgaria.
Ivan BaltadzhievDepartment of Infectious Diseases, Parasitology and Tropical Medicine, Faculty of Medicine, Medical University, 4002 Plovdiv, Bulgaria.
Mariyana Stoycheva-VartigovaResearch Institute, Medical University, 4002 Plovdiv, Bulgaria.

Funding

This research was funded by Medical University - Plovdiv through intramural research project No. 20/2026, entitled "Interventional epidemiological and molecular-genetic project for elimination of vertical and household HBV transmission in high-risk cluste 20/2026
6 · The paper itself

Abstract

Acute hepatitis B virus (HBV) infection is rare during infancy, and severe symptomatic HBV-associated hepatitis is even less common. We describe two siblings who developed severe HBV-associated liver injury during infancy, two years apart, but experienced markedly divergent clinical outcomes. Clinical, laboratory, virological, microbiological, imaging, therapeutic, and follow-up data were retrospectively reviewed. Household members were subsequently tested for HBV and HDV. The first infant, a 5-month-old girl, presented with HBsAg positivity, negative serological markers for HAV, HCV, and HEV, and severe acute liver injury with a fulminant clinical course that resulted in death. Because anti-HBc IgM, HBV DNA, repeat HBsAg testing, and follow-up serology were unavailable, acute HBV infection could not be confirmed, and the episode was therefore classified as presumed HBV-associated fulminant hepatitis. The rapidly fatal clinical course precluded a comprehensive etiological evaluation, and the available medical records did not fully document the diagnostic work-up. The second patient, a 4-month-old boy, presented with serological and molecular evidence of acute HBV infection, including low-level HBV DNA, total anti-HDV positivity of uncertain clinical significance, and positive CMV IgM/IgG serology. He also had a urinary tract infection (UTI) caused by extended-spectrum β-lactamase (ESBL)-producing

Indexed as

Hepatitis BHepatitis B virusDNA, ViralFatal OutcomeFemaleHepatitis B Surface AntigensHepatitis DHumansInfantMaleDNA, ViralHepatitis B Surface AntigensHBV-associated hepatitishepatitis B virushepatitis D virushousehold transmissionimmunoprophylaxisinfantspediatric acute liver failure

Identifiers

PMID42654742
PMCPMC13516367

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.